TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 3 | 2 | 7 | -11 | -16 | -55 | -49 | -20 |
| P | %wins | 100 | 100 | 0 | 0 | 0 | 0 | 33 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/24/15 18:10 | 8/20/15 | KERX | Keryx Biopharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Madison Greg | NY | DO | P,CEO | P | 57 | 5.69 | 12 | 10 | 9 | 117 | D | -34 | -63 | -53 | -44 | -41 | -23 | -11 | -7 | 0 | 14 | -29 | -7 | -40 | -20 |
3/11/15 08:38 | 3/6/15 | KERX | Keryx Biopharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Madison Greg | NY | DO | P,COO | P.a | 80 | 12.53 | 20 | 6 | 6 | 110 | D | 72 | -15 | -16 | -21 | -3 | 3 | 4 | -4 | 3 | 2 | -3 | -21 | -63 | -63 |
3/10/15 17:31 | 3/6/15 | KERX | Keryx Biopharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Madison Greg | NY | DO | P,COO | P | 80 | 12.53 | 20 | 6 | 6 | 110 | D | 74 | -17 | -26 | -18 | -6 | 6 | 6 | -5 | 3 | 4 | -2 | -20 | -63 | -63 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |